Combination of gemcitabine and doxorubicin in rapidly progressive metastatic ... - UroToday Print
UroToday
Metastatic renal cell carcinoma (mRCC) can be rapidly progressive when tumors exhibit sarcomatoid or Fuhrman grade 4 features. Efficacy of gemcitabine (Gem) with doxorubicin (Dox) in sarcomatoid or rapidly progressive mRCC has been reported.

...